Magda Michna's most recent trade in Staar Surgical Co. was a trade of 10,997 Common Stock done . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 10,997 | 43,688 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 10,997 | 10,997 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 5,595 | 38,093 (0%) | 0% | 32.1 | 179,432 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 5,499 | 43,592 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 5,499 | 16,496 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 2,431 | 41,161 (0%) | 0% | 32.1 | 77,962 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 2,199 | 43,360 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 2,199 | 18,695 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 1,118 | 42,242 (0%) | 0% | 32.1 | 35,854 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 1,100 | 43,342 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 1,100 | 19,795 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 559 | 42,783 (0%) | 0% | 32.1 | 17,927 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.69 per share. | 08 May 2026 | 1,680 | 32,691 (0%) | 0% | 26.7 | 44,839 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 33,838 | 33,838 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 14,663 | 29,326 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 14,663 | 33,069 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.84 per share. | 12 Mar 2026 | 6,313 | 29,668 (0%) | 0% | 18.8 | 118,937 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 6,178 | 6,178 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 6,178 | 20,622 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 2,932 | 5,866 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 2,932 | 36,001 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.39 per share. | 12 Mar 2026 | 2,216 | 18,406 (0%) | 0% | 18.4 | 40,752 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.53 per share. | 08 May 2025 | 1,675 | 14,444 (0%) | 0% | 19.5 | 32,713 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 43,989 | 43,989 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 8,798 | 8,798 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Clinical, Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 6,177 | 18,554 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Magda Michna | Chief Clinical, Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 6,177 | 12,356 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Clinical, Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.00 per share. | 12 Mar 2025 | 2,435 | 16,119 (0%) | 0% | 18 | 43,830 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Clinical, Regulatory | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.02 per share. | 08 May 2024 | 1,670 | 12,377 (0%) | 0% | 41.0 | 68,503 | Common Stock |
| Staar Surgical Co. | Magda Michna | Chief Clinical, Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 18,533 | 18,533 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Magda Michna | Chief Clinical, Regulatory | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 16,599 | 16,599 | - | - | Common Stock Options | |
| Staar Surgical Co. | Magda Michna | Chief Clinical, Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 25,955 | 25,955 | - | - | Common Stock Options | |
| Staar Surgical Co. | Magda Michna | Chief Clinical, Regulatory | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 14,047 | 14,047 (0%) | 0% | 0 | Common Stock |